Showing posts with label Industry Analysis. Show all posts
Showing posts with label Industry Analysis. Show all posts

Wednesday, 18 January 2017

Steam Autoclave Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.
The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.
Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings
The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.
Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.
Technological Advancements to Fuel Market’s Growth
The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.
However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.
In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.
On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.
This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Friday, 6 January 2017

Steam Autoclave Market: Business Challenges, Emerging Technologies & Competitive Landscape

The vast rise in the number of surgical procedures undertaken globally, the huge surge in a variety of infections affecting humans, and the alarming rise in the occurrence of hospital-acquired infections has increased the focus on the critical need of effective sanitization practices and devices in healthcare environments. Steam autoclaves, which play a key role in the sterilization of surgical devices and healthcare waste in healthcare environments, are thus witnessing a significant rise in global demand.
In the intensely competitive and consolidated global market for steam autoclaves, emerging economies such as Latin America and Asia Pacific are emerging as the future growth destinations for companies struggling to gain sustainable returns. The market has demonstrated high growth opportunities for advanced product varieties based on novel technologies such as gamma irradiation and E-beam (electron beam) irradiation.
According to a recent market research report by Transparency Market Research, the opportunity in the global steam autoclave market was pegged at US$1.57 bn in 2015. Rising at a promising CAGR of 5.7% over the period between 2016 and 2024, the market is expected to reach US$2.57 bn by 2024.
Q. What role are developed economies playing in the development of the global steam autoclave market?
A. Developed economies across North America and Europe presently hold commanding positions in the market for steam autoclaves and play a key role in its overall development in terms of new product launches and technological advancements. North America alone accounted for a massive 40% of the global steam autoclave market in 2015, chief reason being the vast number of surgeries taking place in the region every year. Reports suggest that in the U.S. alone, nearly 45 mn surgeries take place annually on an average.
This significantly raises the concern and potential of prevalence of hospital-acquired infections, calling the intense need for effective sanitation practices across healthcare infrastructures in North America and Europe. Apart from this, the strict observance of many stringent rules with the aim of enhancing patient safety in healthcare premises is expected to influence the adoption of steam autoclaves in these regions at an encouraging pace in the next few years.
Q. Are developed economies also expected to remain at the forefront of market’s future development?
A. Despite the dominance of North America and Europe, the steam autoclave market is expected to gain the most lucrative returns from emerging economies in regions such as Asia Pacific and Latin America in the next few years. The market for steam autoclave in Asia Pacific, especially, is expected to lead to vast growth opportunities for the global steam autoclave market owing to the increased focus on development of healthcare infrastructure across countries such as India, China, and South Korea. The market in Asia Pacific is also expected to outpace the markets across North America and Europe in terms of growth rate over the period between 2016 and 2024, exhibiting a nearly 8% CAGR.
Owing to this factor, many leading companies in the global steam autoclave market are venturing into the Asia Pacific market through mergers, acquisitions, and consolidation strategies with vendors native to the region or through establishment of operations and manufacturing facilities. Introduction of economic products could help vendors tap the vast untapped opportunities in the region with ease.

Sunday, 9 October 2016

Steam Autoclave Market: Business Challenges, Emerging Technologies & Competitive Landscape

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.
The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.
Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings
The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.
Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.
Technological Advancements to Fuel Market’s Growth
The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.
However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.
In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.
On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.
This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Thursday, 6 October 2016

Contact Lens Market Driven Advancement in Medical Sciences to deal with Ophthalmological Diseases

The global market for contact lenses features a consolidated competitive landscape, with the top four companies, including Johnson & Johnson, The Cooper Companies, Alcona Inc. and Bausch and Lomb, accounting for a share of nearly 68% in the global market in 2015, states Transparency Market Research (TMR) in a new report. Johnson & Johnson, the largest vendor in the market, held nearly 31% share in the global market in the same year.
Volume-wise, the Contact Lens market is expected to rise to 2,135.0 mn units by 2024. TMR also estimates that the global contact lens market, which had a valuation of US$9.74 bn in 2015 in terms of revenue, is expected to expand at a 7.6% CAGR from 2016 through 2024, and rise to US$18.70 bn by 2024. Of the key technologies used for manufacturing contact lenses, the cast molding technology is presently the most preferred, accounting for a share of over 80% of the market’s overall revenues in 2015.
Rising Prevalence of Ophthalmic Disorders and Rising Popularity as Fashion Accessory Boost Global Sales of Contact Lenses
The vast rise in the world’s population that suffers from a variety of ophthalmic disorders has emerged as the primary growth driver of the global contact lens market lately. The rise in younger population with issues such as refractory errors and weakened eyesight have especially increased the global consumption of contact lenses, which are being increasingly preferred for their comfort, convenience, and aesthetics.
The easy availability of colored, disposable, and affordable varieties of contact lenses have also led to the vast rise in their usage as fashion accessories globally. Attempts made by contact lens manufacturers to educate masses about the proper and safe use of contact lenses and the availability of vast product varieties across distant corners of the globe have also helped stimulate the growth of the global contact lens market in the past few years.
Concerns Regarding Damage from Careless Usage Continue to Limit Large-scale Adoption
Owing to the fact that contact lenses are worn directly on the cornea of the eye, they are required to be handled with exceptional care to prevent eye infections, ulcerations and other eye diseases. It is thus a widely known fact that careless handling or storage of contact lenses, or sleeping with the lenses on can have severe implications after the lenses are worn and remains a key challenge hindering the large-scale usage of contact lenses among skeptical consumers.
Along with this, the fact that practitioners are not well equipped to prescribe contact lenses in certain developing economies across regions such as Asia Pacific and Middle East also threatens to limit the overall growth prospects of the global contact lens market to a certain extent.
Emerging Economies to Present Excellent Growth Opportunities
Nevertheless, the vast untapped opportunities in developing regions can allow vendors in the market to gain substantial traction in the next few years. Expansion across these regions will require innovative marketing strategies and ways of educating the masses about the proper usage of contact lenses will have to be adopted. Over the period between 2016 and 2024, the market for contact lenses in Asia Pacific is expected to expand at a considerable CAGR. The APAC market is expected to reach US$4.76 bn by 2024.
Prominent vendors in the market, including Novartis International AG, Menicon Group, STAAR Surgical, Carl Zeiss AG, SynergEyes Inc., Abbott Medical Optics, Inc., Essilor International S.A., Valeant Pharmaceuticals, and Bausch and Lomb have strengthened their hold in regional markets with these approaches. Strategies such as innovation and new product development, high investments in research and development, and exploitation of novel marketing and sales channels have also helped key companies hold sway in the market in the past years. Incorporation of new technologies for upgradation of products and strategic acquisitions entered-in with the aim of expanding product portfolios and market position across regional markets will help companies in beating competition in the next few years.
This review of the global contact lens market is based on a recent market research report published by Transparency Market Research, titled “Contact Lens Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.”

Monday, 26 September 2016

Continuous Glucose Monitoring Market Outlook and Forecast up to 2019

Continuous glucose monitoring systems (CGMS) are portable and real-time glucose monitoring systems employed for glucose level measurement from time to time from the body of a patient. These systems make use of a wireless technology for the transmission of glucose readings which are taken from the interstitial fluid of the skin cells of the patient, unlike the measurement of glucose levels present in the blood which happens in case of blood glucose meters. The swiftly increasing diabetic population globally has substantially raised the preference for effectual diabetes management systems.
Transparency Market Research (TMR), a market intelligence company, studies the continuous glucose monitoring market in detail. It provides the reasons behind their increased demand and the type of devices leading the market.
Research Report:
Q. Why are CGMS gaining popularity over the conventionally utilized glucose monitoring systems?
The utilization of CGMS is immensely rising and they are overtaking the conventionally utilized glucose monitoring systems owing to them being user friendly, more accurate, and their provision of presenting access to real-time trends and values. In addition, continuous glucose monitoring systems aid in the management of diabetes, particularly in patients having diabetes I and also aid in lowering long-terms complexities related to diabetes. Furthermore, the increasing technological innovations are also amongst the prime factors behind the increasing employment of these systems, making the control and management of diabetes mellitus relatively simpler. The early identification of hypoglycemic and hyperglycemic levels by the utilization of CGMS devices will also fuel their demand over other types of blood glucose monitoring systems.
Q What are the key opportunities and which factors may negatively impact the growth of the market?
There are numerous growth opportunities in the market as a number of companies have made investments in the research and development of CGMS, thus making the management and control of diabetes easier. For instance, Dexcom, Inc. has developed the next generation disposable continuous glucose monitoring device and it will be introduced in the market by 2021. This launch will positively impact the growth of the market. In addition, the artificial pancreas’ approval, which makes the utilization of CGMS mandatory has also emerged as a key opportunity in the global continuous glucose monitoring devices market. However, the dearth in the reimbursement options and the strict regulatory norms in some nations are amongst the crucial factors impeding the growth of the continuous glucose monitoring market.
Q. Which device/brand and region have dominated the market?
The segment of Guardian Real Time CGM System led the market in 2012 and was trailed by Dexcom Seven Plus CGM system. On the other hand, in the forecast horizon between 2013 and 2019, the development of the segment of FreeStyle Navigator will witness immense growth.
Geographically, North America held a dominant share in the market for CGMS on the basis of revenue in 2012. This is due to the increasing geriatric population, the increasing obesity, and the growing acceptance of cutting-edge devices in this region. North America was trailed by Europe, which was further followed by Asia Pacific, constituting the third position in the market. In addition, Asia Pacific is predicted to hold the most lucrative opportunities in the growth of the market in forthcoming years.

Friday, 12 August 2016

Companion Diagnostics Market Responds to Impressive Progress in Medicine and Healthcare

Due to the dominance of the top three players in the global companion diagnostics market, the nature of the market is highly oligopolistic, says Transparency Market Research in a new study. The leading companies operating in the market are focusing on protecting their patent rights to retain exclusivity. The top three companies in the companion diagnostics market are Roche Holdings followed by Qiagen N.V., and Agilent Technologies. Together they comprise approximately 80.4% of the overall global market in 2012.
In order to rake in a greater share of revenues, many small and large players are competing to co-develop companion diagnostics by collaborating with pharmaceutical manufacturers. In this regard, companies are also seeking defensive patents for their technology, products, and tests to restrain other companies from the usage of their exclusive tests.
Regulatory Changes to Ensure Adoption of Companion Diagnostics
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting its focus towards personalized medicine.
According to TMR analyst, the implementation of well-structured regulatory policies will help in the development of effective companion diagnostics leading to a growth in the market. As a result of the FDA guideline in the U.S. regarding the approval of targeted therapeutic along with its companion drug, two targeted therapeutics, one of Abbott Laboratories and the other of Roche Holdings, were approve along the line. Currently, various regulatory agencies around the world are in support for the use of companion diagnostics for the development and commercialization of prescription drugs used in targeted therapeutics. Thus, the change in regulatory policies is expected to boost the adoption of companion diagnostics globally.
Rising Influence of Advocacy Groups and Clinical Societies to Negatively Affect Demand for Companion Diagnostics
As the companion diagnostics field is still in its infancy, the opinions of various institutions, organizations, societies, and groups have a deep impact on the acceptance of these diagnostics.
The opinions and reviews of clinical societies and advocacy groups are likely to influence the end users leading to hampering the sales and acceptance of companion diagnostics. However, many clinical societies and advocacy groups also promote the use and acceptance of these tests.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387
Demand for Companion Diagnostics in Treating Wide Range of Diseases to Help Vendors Expand Business
The expansion of companion diagnostics into new areas such as oncology, CNS disorders, infectious diseases, and metabolism disorders has provided the companies of companion diagnostics with new growth opportunities. Different pharmaceutical and diagnostics companies are investing in the development of companion drugs and due to the expansion in the application scope, these companies are expected to gain substantial growth opportunities.
The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to 2019 to reach US$5.58 bn by 2019. The market was worth US$2.80 bn in 2015. North America is projected to dominate the market until 2019 with a market worth US$2.18 bn, followed by Europe. The breast cancer companion diagnostic segment is estimated to lead the global market in terms of indication by 2019 with a market worth US$2,531.4 mn.
The review has been based on the findings of a TMR report titled, “Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Wednesday, 13 April 2016

Forensic Technologies Market - An Overview of Growth Factors

Medical_DevicesAs technology penetrates practically all walks of life, it is no surprise that solving crimes is driven by modern technologies and methods. Today scientists use retinal scanning, DNA tests, mass spectrometry, high-performance liquid chromatography, and other advanced technologies to reconstruct crimes and accidents. In the entire operative, right from the collection of evidence at crime site to presentation of investigated results in courts of law, forensic technology has dramatically improved the quality and precision of criminal investigations.
Of the several investigating methodologies, DNA profiling is extensively used and is expected to rise at a CAGR of 11% for the 2013-2019 period. DNA profiling is significant for crime investigations that are otherwise impossible to crack due to insufficient non-DNA-based evidence. Currently, DNA profiling is rising in demand rapidly, as law enforcement agencies are considerably dependent on this for criminal investigation.
Standardization of Processes to Lower Forensic Technologies Market Value in North America and Europe
Transparency Market Research states that the global forensic technologies market will expand at a CAGR of 12.4% between 2013 and 2019. This will result in the market’s valuation reaching US$17.7 bn by 2019, increasing from US$8.3 bn in 2012.
In terms of geography, North America and Europe are the leading markets for forensic technologies. In 2012, the global market was dominated by North America, which was closely followed by Europe, which resulted in the two regions accounting the majority share in the global market. This is because forensic technologies such as biometrics/fingerprints, DNA profiling, and firearms identification are a standard part of the criminal investigation procedure in these regions and are carried out through automated systems. Further standardization of processes will result in reduced expenditure on end-to-end crime analysis and a decline in the value of forensic services in these regions.
Adoption of Technology-based Criminal Investigation Rising in Asia Pacific, RoW Forensic Technologies Markets
Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=819
By the end of 2019, Asia Pacific and Rest of the World are expected to collectively hold a share of close to 60% in the global market. In these regions, several countries have initiated DNA database programs on a mass scale to be prepared for future eventualities. For instance, the Dubai police is investing heavily on building forensic technologies/services infrastructure and for purchasing hi-tech forensic equipment and supplies. Thus, the Middle East market will render attractive growth opportunities for forensic equipment providers. A multitude of other favorable factors will propel the growth of the forensic technologies/services market in these regions; hence, Asia Pacific and Rest of the World will garner a significant share in the global forensic technologies market going forward.
Top players that are involved in forensic technologies market globally are NMS Labs Inc., Spex Forensics, GE Healthcare Life Sciences, Pyramidal Technologies Ltd., LGC Forensics, and Eurofins Medigenomix GmbH.

Thursday, 7 April 2016

Global Breath Analyzers Market to Reach US$4.5 bn by 2019 owing to Rise in Number of Road Accidents

Breath AnalyzersTransparency Market Research has published a new report on the global breath analyzers market. As per the report, the global breath analyzers market is expected to progress from US$402 mn in 2012 to US$4.5 bn by 2019. The report, titled ‘Breath Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global breath analyzers market is predicted to expand at a 41.30% CAGR during the period from 2013 to 2019 due to factors such as the rise in the incidence of diseases due to increasing drug abuse and increase in the number of road accidents because of excessive alcohol consumption.
Breath analyzers are medical equipment used for estimating the alcohol content of a person from an exhaled breath. These devices were first introduced in the market way back in the 1940’s for the detection of alcohol in the human body. Advancements in research and development have now advanced the use of breath analyzers or breath testing devices in the medical and healthcare sector for accurate diagnosis. Breath testing devices work on the simple principle of the measurement of gases in an exhaled breath at a low concentration. Owing to their non-invasive, accurate, and quick diagnosis, breath analyzers have gained tremendous importance in the recent past.
As per the World Health Organization (WHO), around 2.5 million people die every year due to excessive alcohol consumption. 20% of drivers injured due to road accidents are found to have consumed alcohol. The rise in the number of road accidents due to drinking and driving has created growth opportunities for the global breath analyzers market.
Government support and the introduction of new breath analyzer devices are expected to accelerate the growth of the global breath analyzer market in the years to come. Considering the many advantages of breath testing devices, leading players are focusing on developing breath analyzer devices for the detection of various diseases such as tuberculosis, asthma, and others.
The global breath analyzers market is segmented on the basis of application, geography, and technology. Based on geography, the global breath analyzer market is divided into North America, Asia Pacific, Europe, and Rest of the World. In 2012, in terms of revenue, North America dominated the global breath analyzer market due to the growing number of people addicted to or regularly using alcohol. Europe is predicted to be the second largest market in the global breath analyzers market in the years to come.
By application, the global breath analyzers market is classified into alcohol detection, drug abuse detection, H. pylori infection detection, asthma detection, and tuberculosis detection. At present, the global breath analyzers market is dominated by the tuberculosis detection segment.
Some of the prominent players operating in the global breath analyzers market are Dragerwerk AG & Co, Intoximeters, Inc., Lifeloc Technologies, Inc., Alcohol Countermeasure Systems, Inc., and Quest Products. Based on technology, the global breath analyzers market is classified into infrared absorption fuel cell, and semiconductor sensor. Currently, the global breath analyzers market is led by the fuel cell technology.

Monday, 28 September 2015

Sterilization Equipment and Disinfectants Market to Report Strong CAGR of 8.5% to reach US$ 9,153.9 Million by 2019

A new market study published by Transparency Market Research (TMR) presents a comprehensive analysis of the global sterilization equipment and disinfectants market. The market study talks about the current market situation and its impact on the future of the sterilization equipment and disinfectants market around the world. The report is titled “Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.
Sterilization equipment and disinfectants are used to sterilize medical instruments, pharmaceutical components, and laboratory equipment. Sterilization equipment and disinfectants are essential components for infection control, as medical devices need sterilization and disinfection after being used, since they get contaminated with bioactive components.
The global market for sterilization equipment and disinfectants had reached a value of US$5.13 billion in 2012. It is estimated that the market will register a cumulative average growth rate of 8.5% during 2013 to 2019, and reach US$9.15 billion by 2019.
The market research report, inclusive of a detailed analysis of past performances, current trends, and future prospects of the global sterilization equipment and disinfectants market, makes for an informative and engaging piece of study.
The research report discusses the types and applications of sterilization equipment and disinfectants, in which sterilization equipment holds around 70% of the market based on revenue. The market for sterilization equipment is likely to rise at a 9.1% CAGR, which is expected to be the highest among all segments from 2013 to 2019. This development is credited to the user-friendliness and broad application area of the sterilization equipment market. In addition to this, sterilization equipment is safer to use than active disinfectants, which come with their own set of possible side-effects.
In 2012, the heat sterilization equipment market held the largest share on the basis of revenue in the total sterilization equipment market. It is likely to increase at an 8.6% CAGR from 2013 to 2019. This development is credited to the fact that heat sterilization equipment is more user-friendly and safer as compared to low-temperature sterilization equipment and others. However, low temperature sterilization is likely to register a growth at the highest, 10.9% CAGR during 2013 to 2019.
Browse the full Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type - Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/sterilization-equipment-market.htm
Regionally, North America held the largest share of the global sterilization equipment and disinfectants market, holding more than 40% of the sterilization equipment and disinfectants industry in 2012. Increase in demand for non-disposable surgical devices such as distracters, endoscopy devices, and forceps are the growth drivers behind the rise of the sterilization equipment and disinfectants market in North America. Asia Pacific is the fastest developing sterilization equipment and disinfectants market, increasing at a 10.9% CAGR from 2013 to 2019.

Wednesday, 25 February 2015

Continuous Glucose Monitoring MarketContinuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

download (1)
Continuous glucose monitoring devices are smart, tiny automated machines that provide a wide range of information about a patient’s fluctuating blood glucose levels  such as the frequency, magnitude, direction, duration and causes of the glucose fluctuation in the patient’s body and help in taking optimal treatment decisions well before the outburst of an emergency situation. 
Conventional glucose mentoring systems, which require obtaining a speck of blood on a lancing device and analyzing the glucose level in the blood sample thus obtained by using a glucose meter, are generally used once a day by most patients. Continuous glucose monitoring systems, on the other hand, allow for a continuous monitoring of blood glucose levels per day. As such a close inspection of trends in a patient’s glucose level fluctuation is possible, allowing the identification and prevention of emergencies.
The difference between a conventional glucose mentoring system and a continuous glucose monitoring system is similar to the difference between a conventional camera and a security video surveillance camera. The camera takes accurate snapshots at discrete moments, specifically at the moments when it is manually operated. The small set of pictures thus taken can be carefully studied to analyze any given situation but no specific data about trends in the situation under-cover can be gathered from the pictures.
The security surveillance camera, on the other hand, records video streams of multiple frames, albeit poorly focused, and displays a sequential array of these recorded frames. The trend observable from the array of frames can be used to predict future. But, too much information is captured on each frame, making it quite difficult to study each frame carefully. Also, no manual interaction is required for it to record something, except for the initial set-up efforts to turn it on. 
The two types of glucose monitors essentially have the similar kind of differences:
A conventional glucose monitor can measure glucose levels at discrete intervals almost accurately, whereas a continuous glucose monitor can measure glucose levels at multiple moments with fair accuracy. A conventional glucose monitor cannot predict future glucose levels as it does not study or analyze trends from past results. With a continuous glucose monitor, however, this is possible as a result of its capability of capturing and analyzing trends by making use of past results.  Also, conventional glucose monitors require manual efforts to operate whereas continuous glucose monitors are automated.
Looking back at the camera analogy, we know that a security surveillance camera is often more useful than a regular camera in cases when the outcome is more important than just the momentary frames. Correspondingly, the best way to monitor blood glucose levels often may be a continuous glucose monitor rather than a conventional glucose monitor. 
The technology used in the currently available continuous glucose monitors is either the continuous measurement of the interstitial fluid (ISF) that involves minimal invasiveness or by applying electromagnetic currents through the skin to the blood vessels of the body that involves no invasion in the body.
The most common method of these two methods is the one that measures the ISF through minimal invasion in the body. It involves fixing a sensor into the abdominal wall or the arm so that it comes in contact with the ISF of one’s body. The ISF is harvested by using various methods and is then delivered to an external sensor that monitors the glucose levels.
We are currently offering a flat 15% discount on all purchases until end of the March 2015!
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169
This technique is called minimally invasive as the sensor is pricked on the skin only as deep as to compromise the barrier of skin and not puncturing any blood vessel.
Continuous glucose monitors are basically simple-looking devices that produce complex-looking data and this can, especially at times when the user is not well educated about the correct meaning of these data-pieces, can disguise the patient in taking erroneous corrective measures. Also, it should be understood that the glucose levels are prone to rise at times such as right after eating something or after a period of exercise. Such conditions should not prompt the patient in taking doses of insulin or eating something, to manage the sudden fluctuation. Instead the patient should be prompted to check the glucose level by finger-sticking a blood sample through a conventional glucose monitor. 
It is obvious that continuous glucose monitoring techniques are currently less accurate than the conventional glucose monitors. But they are more beneficial as they provide data every frequent interval and keep feeding data throughout the day and night. Most systems also incorporate alarms for extreme results that may indicate cases of hyper and hypoglycemia. Also, when these systems are in use almost continuously over extensive time periods, there is huge possibility that significant improvements in controlling glucose levels can be easily achieved.
About us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse The Market Research Blog :
https://marketsresearchindustry.wordpress.com/